Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Maravai LifeSciences Holdings, Inc.
www.maravai.comAI Executive Summary
AI-powered analysis of 8-K filing content
Maravai LifeSciences secured a new $150 million term loan and $30 million revolving credit facility maturing in 2032, using proceeds to refinance and prepay prior debt obligations, enhancing liquidity and reducing overall debt burden.
Key Takeaways
New credit agreement provides $150M term loan and $30M revolving facility, both maturing June 2, 2032
Company used new term loan proceeds plus $98.5M in cash to fully prepay and terminate prior Credit Agreement
2 more takeaways